Interestingly, we analyzed the significance of RCC2 in terms of clinical prognosis by Kaplan–Meier survival analysis, and the results revealed that high RCC2 expression indicated poor prognosis in AML patients (Fig. 6c, d). Here, RCC2 is linked to acute myeloid leukemia.